Simplification to atazanavir/ritonavir plus lamivudine versus maintaining atazanavir/ritonavir+2NRTIs in virologically suppressed HIV-infected patients: 96-week data of the ATLAS-M trial

Roberta Gagliardini, Andrea De Luca, Eq Roldan et al.|Unknown|2016

Cited by 11